Literature DB >> 33642489

Multiple-line Chemotherapy for a Patient with Unresectable Mucinous Cystic Neoplasm of the Pancreas.

Haruo Miwa1, Kazuya Sugimori1, Tomohiro Ishii1, Akihiro Funaoka1, Hiromi Tsuchiya1, Yoshimasa Suzuki1, Makoto Sugimori1, Masaki Nishimura1, Yuichiro Tozuka1, Satoshi Komiyama1, Takeshi Sato1, Takashi Kaneko1, Kazushi Numata1, Shin Maeda2.   

Abstract

A 74-year-old woman with a cyst in her pancreatic tail was referred to our hospital. Computed tomography confirmed a large cystic lesion with irregular wall thickening, abdominal lymph node swelling, and ascites. We diagnosed her with an unresectable mucinous cystic neoplasm, since ascites cytology revealed adenocarcinoma. The patient received chemotherapy up to the fifth line for 55.2 months. Gemcitabine plus nab-paclitaxel and modified FOLFORINOX achieved a partial response with a progression-free survival time of 12.1 and 20.4 months, respectively. The overall survival time from the beginning of first-line chemotherapy was 69.4 months.

Entities:  

Keywords:  antineoplastic combined chemotherapy protocols; palliative therapy; pancreatic cancer; pancreatic cyst

Year:  2021        PMID: 33642489     DOI: 10.2169/internalmedicine.6755-20

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  1 in total

1.  A case of pancreatic mucinous cystadenocarcinoma with malignant ascites without recurrence for more than 8 years after surgery.

Authors:  Shun Tezuka; Makoto Ueno; Satoshi Kobayashi; Taito Fukushima; Ryuji Nasu; Kota Washimi; Naoto Yamamoto; Soichiro Morinaga; Manabu Morimoto; Shin Maeda
Journal:  Clin J Gastroenterol       Date:  2022-05-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.